Literature DB >> 2153706

Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment.

A S Maisel1, K U Knowlton, P Fowler, A Rearden, M G Ziegler, H J Motulsky, P A Insel, M C Michel.   

Abstract

The current studies were undertaken to explore the relationship between enhanced sympathetic nervous activity and lymphocyte subset distribution in three settings: congestive heart failure, dynamic exercise, and beta-adrenergic agonist treatment. We compared the number and subset distribution of circulating lymphocytes in 36 patients with congestive heart failure and 31 age-matched control subjects. The number of circulating lymphocytes was lower in heart failure than in control. This was due to a reduction in Tsuppressor/cytotoxic and natural killer cells without significant alteration of Thelper cells. The extent of the alteration was similar in patients with idiopathic and ischemic heart failure, but the reduction was more pronounced in patients with New York Heart Association class III-IV than in class I-II. The plasma catecholamine elevation in heart failure was also independent of etiology but more pronounced in the more severely ill patients. We also assessed lymphocyte subsets after acute stimulation of sympathetic activity by dynamic exercise and after treatment with the beta-adrenergic agonist terbutaline. Dynamic exercise until exhaustion increased the number of circulating lymphocytes in healthy controls and heart failure patients in a subset-selective manner. By contrast, a 7-d treatment with terbutaline caused a reduction in the circulating number of lymphocytes in some subsets that was identical to that seen in heart failure patients. We conclude that prolonged sympathetic activity reduces the number of circulating lymphocytes by a beta-adrenergic mechanism. Such alterations might be involved in the pathophysiology of heart failure and other disease states involving increased activity of the sympathetic nervous system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153706      PMCID: PMC296446          DOI: 10.1172/JCI114460

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  A new method for isolation of human lymphocyte subsets reveals differential regulation of beta-adrenergic receptors by terbutaline treatment.

Authors:  A S Maisel; P Fowler; A Rearden; H J Motulsky; M C Michel
Journal:  Clin Pharmacol Ther       Date:  1989-10       Impact factor: 6.875

2.  Stress-induced modulation of the immune response.

Authors:  A A Monjan; M I Collector
Journal:  Science       Date:  1977-04-15       Impact factor: 47.728

3.  Stress-induced suppression of immunity in adrenalectomized rats.

Authors:  S E Keller; J M Weiss; S J Schleifer; N E Miller; M Stein
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

4.  Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy.

Authors:  J L Anderson; J F Carlquist; E H Hammond
Journal:  Lancet       Date:  1982-11-20       Impact factor: 79.321

5.  Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis.

Authors:  R Eckstein; W Mempel; H D Bolte
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

6.  The beta-adrenergic receptor in human lymphocytes: subclassification by the use of a new radio-ligand, (+/-)-125 Iodocyanopindolol.

Authors:  O E Brodde; G Engel; D Hoyer; K D Bock; F Weber
Journal:  Life Sci       Date:  1981-11-23       Impact factor: 5.037

7.  Coping and immunosuppression: inescapable but not escapable shock suppresses lymphocyte proliferation.

Authors:  M L Laudenslager; S M Ryan; R C Drugan; R L Hyson; S F Maier
Journal:  Science       Date:  1983-08-05       Impact factor: 47.728

8.  The sympathetic nervous system in primary hypertension.

Authors:  M A Weber; J I Drayer
Journal:  Miner Electrolyte Metab       Date:  1982-02

9.  Adrenergic receptors in human and experimental pheochromocytoma.

Authors:  M D Snavely; H J Motulsky; D T O'Connor; M G Ziegler; P A Insel
Journal:  Clin Exp Hypertens A       Date:  1982

10.  Epinephrine-induced changes in the distribution of lymphocyte subsets in peripheral blood of humans.

Authors:  B Crary; S L Hauser; M Borysenko; I Kutz; C Hoban; K A Ault; H L Weiner; H Benson
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

View more
  28 in total

1.  Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects.

Authors:  Y Zoukos; T Thomaides; D V Pavitt; J P Leonard; M L Cuzner; C J Mathias
Journal:  Clin Auton Res       Date:  1992-06       Impact factor: 4.435

2.  Effect of intense wrestling exercise on leucocytes and adhesion molecules in adolescent boys.

Authors:  D Nemet; P J Mills; D M Cooper
Journal:  Br J Sports Med       Date:  2004-04       Impact factor: 13.800

3.  Effect of long-term beta2-agonist dosing on human cardiac beta-adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte beta-receptors.

Authors:  F Qing; S U Rahman; M J Hayes; C G Rhodes; P W Ind; T Jones; J M Hughes
Journal:  J Nucl Cardiol       Date:  1997 Nov-Dec       Impact factor: 5.952

Review 4.  The immunological axis in heart failure: importance of the leukocyte differential.

Authors:  Muthiah Vaduganathan; Stephen J Greene; Javed Butler; Hani N Sabbah; Eduard Shantsila; Gregory Y H Lip; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

5.  Relation between beta-adrenergic receptor density and lymphocyte proliferation associates with acute stress.

Authors:  L Redwine; F Jenkins; A Baum
Journal:  Int J Behav Med       Date:  1996

6.  Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.

Authors:  A Grove; L C McFarlane; B J Lipworth
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

7.  Endothelial progenitor cells: what use for the cardiologist?

Authors:  Aurangzeb Siddique; Eduard Shantsila; Gregory Yh Lip; Chetan Varma
Journal:  J Angiogenes Res       Date:  2010-02-22

8.  Interleukin-2 enhances the cytotoxic activity of circulating natural killer cells in patients with chronic heart failure.

Authors:  Heng-Chen Yao; Shu-Qin Liu; Ke Yu; Min Zhou; Le-Xin Wang
Journal:  Heart Vessels       Date:  2009-07-22       Impact factor: 2.037

9.  Cyclic AMP counteracts mitogen-induced inositol phosphate generation and increases in intracellular Ca2+ concentrations in human lymphocytes.

Authors:  L J van Tits; M C Michel; H J Motulsky; A S Maisel; O E Brodde
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

10.  Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure.

Authors:  Stephan von Haehling; Joerg C Schefold; Ewa Jankowska; Wolfram Doehner; Jochen Springer; Kristin Strohschein; Sabine Genth-Zotz; Hans-Dieter Volk; Philip Poole-Wilson; Stefan D Anker
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.